Literature DB >> 23124938

Overview of influenza viruses.

Stephan Pleschka1.   

Abstract

The influenza virus (IV) is still of great importance as it poses an immanent threat to humans and animals. Among the three IV-types (A, B, and C) influenza A viruses are clinically the most important being responsible for severe epidemics in humans and domestic animals. Aerosol droplets transmit the virus that causes a respiratory disease in humans that can lead to severe pneumonia and ultimately death. The high mutation rate combined with the high replication rate allows the virus to rapidly adapt to changes in the environment. Thereby, IV escape the existing immunity and become resistant to drugs targeting the virus. This causes annual epidemics and demands for new compositions of the yearly vaccines. Furthermore, due to the nature of their segmented genome, IV can recombine segments. This can eventually lead to the generation of a virus with the ability to replicate in humans and with novel antigenic properties that can be the cause of a pandemic outbreak. For its propagation the virus binds to the target cells and enters the cell to replicate its genome. Newly produced viral proteins and genomes are packaged at the cell membrane where progeny virions are released. As all viruses IV depends on cellular functions and factors for their own propagation, and therefore intensively interact with the cells. This dependency opens new possibilities for anti-viral strategies.

Entities:  

Mesh:

Year:  2013        PMID: 23124938     DOI: 10.1007/82_2012_272

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  22 in total

Review 1.  Current Immunological and Clinical Perspective on Vaccinations in Multiple Sclerosis Patients: Are They Safe after All?

Authors:  Shani Witman Tsur; Eli Adrian Zaher; Meydan Tsur; Karolina Kania; Alicja Kalinowska-Łyszczarz
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

Review 2.  Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages.

Authors:  Shuai Xia; Lijue Wang; Yun Zhu; Lu Lu; Shibo Jiang
Journal:  Signal Transduct Target Ther       Date:  2022-07-19

3.  Identification of Novel Fusion Inhibitors of Influenza A Virus by Chemical Genetics.

Authors:  Kin Kui Lai; Nam Nam Cheung; Fang Yang; Jun Dai; Li Liu; Zhiwei Chen; Kong Hung Sze; Honglin Chen; Kwok-Yung Yuen; Richard Yi Tsun Kao
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

Review 4.  Stem cell therapy: a potential approach for treatment of influenza virus and coronavirus-induced acute lung injury.

Authors:  Jiang Du; Han Li; Jie Lian; Xinxing Zhu; Liang Qiao; Juntang Lin
Journal:  Stem Cell Res Ther       Date:  2020-05-24       Impact factor: 6.832

Review 5.  Zoonotic Potential of Influenza A Viruses: A Comprehensive Overview.

Authors:  Ahmed Mostafa; Elsayed M Abdelwhab; Thomas C Mettenleiter; Stephan Pleschka
Journal:  Viruses       Date:  2018-09-13       Impact factor: 5.048

6.  A newly developed tetraplex real-time RT-PCR for simultaneous screening of influenza virus types A, B, C and D.

Authors:  Dinah Henritzi; Bernd Hoffmann; Silke Wacheck; Stefan Pesch; Georg Herrler; Martin Beer; Timm C Harder
Journal:  Influenza Other Respir Viruses       Date:  2018-10-22       Impact factor: 4.380

Review 7.  Selenium, Selenoproteins and Viral Infection.

Authors:  Olivia M Guillin; Caroline Vindry; Théophile Ohlmann; Laurent Chavatte
Journal:  Nutrients       Date:  2019-09-04       Impact factor: 5.717

Review 8.  Influenza Vaccination and Guillain-Barré Syndrome: Reality or Fear.

Authors:  Arefeh Babazadeh; Zeinab Mohseni Afshar; Mostafa Javanian; Mousa Mohammadnia-Afrouzi; Ahmad Karkhah; Jila Masrour-Roudsari; Parisa Sabbagh; Veerendra Koppolu; Veneela KrishnaRekha Vasigala; Soheil Ebrahimpour
Journal:  J Transl Int Med       Date:  2019-12-31

Review 9.  From virus to inflammation, how influenza promotes lung damage.

Authors:  Mitchell Klomp; Sumit Ghosh; Sohail Mohammed; M Nadeem Khan
Journal:  J Leukoc Biol       Date:  2020-09-08       Impact factor: 6.011

Review 10.  Antiviral natural products and herbal medicines.

Authors:  Liang-Tzung Lin; Wen-Chan Hsu; Chun-Ching Lin
Journal:  J Tradit Complement Med       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.